GLP1 weight loss drugs linked to nutrient shortages in exploratory study
A study suggests appetite suppressants such as Wegovy and Mounjaro are linked to inadequate nutrient intake, while awareness among patients remains low.
FTMQ Health, written by our newsroom0 views

Appetite suppressants such as Wegovy and Mounjaro are associated with inadequate intakes of key nutrients and energy in some people, Medical Xpress reported. The findings come from a small exploratory study published in the journal BMJ Nutrition Prevention and Health. [1]
Medical Xpress reported that there is low awareness of this potential side effect among individuals taking the medications. The outlet noted that this occurs amid limited nutritional guidance provided by clinicians. [1]
Glucagon-like peptide-1 receptor agonists, also known as GLP-1 agonists or GLP-1s, are a class of medications that activate the GLP-1 receptor. These medications cause reduced blood sugar, reduced appetite, and reduced energy intake. Incretin mimetics mimic the actions of incretin hormones such as GLP-1 and GIP. [2]
As FTMQ Health reported earlier, dietary choices and nutrient intake remain critical public health topics. Previous reports highlighted how nutritional components like whole grains lower certain health risks, whereas unfortified dietary swaps can lead to micronutrient shortages of iodine, calcium, riboflavin, and vitamin B12. [3][4]
In short
- Wegovy and Mounjaro are linked to inadequate key nutrient and energy intake in some individuals.
- The study on GLP-1 drugs was published in BMJ Nutrition Prevention & Health.
- GLP-1 receptor agonists activate GLP-1 receptors to reduce blood sugar, appetite, and energy intake.
- Awareness of potential nutrient deficiencies remains low among patients taking GLP-1 medications.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some peopleMedical Xpress, 5h ago (the report this story comes from)
Background
- [2]GLP-1 receptor agonist on Wikipedia
- [3]Ultra processed foods show no overall link to colorectal cancer risk FTMQ Health, 33d ago
- [4]Plant milk swaps may cause micronutrient shortages without fortified foods FTMQ Health, 13d ago
Our newsroom writes these reports with the help of software, from the 4 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- GLP1 weight loss drugs linked to increased risk of nail detachmentFitness, 36d ago
- Structured support may limit weight regain after stopping GLP-1 drugsTop Stories, 41d ago
- NHS Western Isles prescribes weight loss medication at highest rate in ScotlandTop Stories, 20d ago
- Residential radon exposure linked to higher heart failure risk in womenTop Stories, 9d ago
- WHO guidelines advise against obesity drugs for children under tenTop Stories, 41d ago
More in Top Stories
- United States updates federal health data privacy regulations for patient records4h ago
- Apple launches large study to evaluate health artificial intelligence app4h ago
- United States loses official measles elimination status following severe outbreak4h ago
- Large and small waist sizes linked to higher death risk4h ago
- UK government to end Palantir NHS England contract in 20291d ago
- FDA approves new Roche breast cancer drug Wilserdly1d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.